Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of Moderate-to-Severe Atopic Dermatitis in Children?
Presented by the Atopic Dermatitis & Psoriasis Focused Study Group, and moderated by Dr. Minnelly Luu, Drs. Amy Paller, Elaine Siegfried, Jeff Yu, and A. Yasmine Kirkorian have a spirited discussion about the safety of JAK inhibitors in children, what interventions to try first, and the research that is still needed. Listen to learn more.
Episode One
Episode Two
Episode Three
Minnelly Luu, MD
Moderator
Amy Paller, MD
Program Guest
Elaine Siegfried, MD
Program Guest
A. Yasmine Kirkorian, MD
Program Guest
Jeff Yu, MD
Program Guest
Four Star Charity Navigator
